Literature DB >> 1483498

Effect of tetracycline on mefloquine pharmacokinetics in Thai males.

J Karbwang1, K Na Bangchang, D J Back, D Bunnag, W Rooney.   

Abstract

The kinetics of a single oral dose of mefloquine given either alone or with tetracycline has been studied in 20 healthy Thai male volunteers. There was a significantly higher maximum whole blood mefloquine concentration after coadministration with tetracycline (1600 vs 1160 ng.ml-1), as well as a significantly reduced terminal half-life (14.4 vs 19.3 days), mean residence time (11.9 vs 16.0 days) and volume of distribution at steady state (13.3 vs 19.9 1.kg-1). Although there was no significant change in the AUC from zero time to infinity, the AUC from zero time to 7 days was significantly increased by tetracycline (6.18 vs 4.76 micrograms.ml-1.day). The changes in mefloquine disposition after tetracycline treatment are probably due to a reduction in enterohepatic recycling. The initial increase in mefloquine AUC without an apparent increase in side-effects suggests that this combination may have a place in the treatment of multi-drug resistant falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483498     DOI: 10.1007/bf02285105

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Effect of ampicillin on mefloquine pharmacokinetics in Thai males.

Authors:  J Karbwang; K Na Bangchang; D J Back; D Bunnag
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Biliary excretion of ampicillin, metampicillin and carbenicillin.

Authors:  M Pinget; J M Brogard; J Dauchel; J Lavillaureix
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

3.  Determination of mefloquine in biological fluids using high performance liquid chromatography.

Authors:  J Karbwang; P Molunto; K Na Bangchang; D Bunnag
Journal:  Southeast Asian J Trop Med Public Health       Date:  1989-03       Impact factor: 0.267

4.  Tetracycline for chloroquine-resistant malaria.

Authors:  N White
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

5.  Type II mefloquine resistance in Thailand.

Authors:  E F Boudreau; H K Webster; K Pavanand; L Thosingha
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

Review 6.  Quinine and quinidine in malaria in Thailand.

Authors:  D Bunnag; T Harinasuta
Journal:  Acta Leiden       Date:  1987

7.  Response of Kampuchean strains of Plasmodium falciparum to antimalarials: in-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro.

Authors:  M Giboda; M B Denis
Journal:  J Trop Med Hyg       Date:  1988-08

Review 8.  Clinical pharmacokinetics of mefloquine.

Authors:  J Karbwang; N J White
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

9.  Plasma quinine levels in patients with falciparum malaria when given alone or in combination with tetracycline with or without primaquine.

Authors:  J Karbwang; P Molunto; D Bunnag; T Harinasuta
Journal:  Southeast Asian J Trop Med Public Health       Date:  1991-03       Impact factor: 0.267

10.  Cloning and characterization of mefloquine-resistant Plasmodium falciparum from Thailand.

Authors:  H K Webster; S Thaithong; K Pavanand; K Yongvanitchit; C Pinswasdi; E F Boudreau
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

View more
  3 in total

1.  Mefloquine pharmacokinetics in healthy subjects and in peptic ulcer patients after cimetidine administration.

Authors:  J A Kolawole; A Mustapha; I Abudu-Aguye; N Ochekpe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Jul-Dec       Impact factor: 2.441

Review 2.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Effects of tetracycline on the pharmacokinetics of halofantrine in healthy volunteers.

Authors:  Peter U Bassi; Cyprian O Onyeji; Otas E Ukponmwan
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.